NCT01534390View on ClinicalTrials.gov

Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2015

Conditions
Systemic Inflammation
Interventions
DEVICE

In-line microfilter (Supor IV Filter; Pall Corporation, Port Washington, New York)

use of in-line microfilters with a pore size of 0,2 mcm and 1,2 mcm (only if parenteral nutrition is administered) at all intravenous accesses

Trial Locations (1)

5020

Department of Anesthesiology, perioperative and intensive care medicine, Salzburg General Hospital and Paracelsus Private Medical University, Salzburg

All Listed Sponsors
lead

University of Salzburg

OTHER

NCT01534390 - Influence of In-line Microfilters on Systemic Inflammation in Adult Critically Ill Patients | Biotech Hunter | Biotech Hunter